Sumitomo Mitsui DS Asset Management Company Ltd Purchases 946 Shares of CME Group Inc. (NASDAQ:CME)

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 42,413 shares of the financial services provider’s stock after buying an additional 946 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in CME Group were worth $8,932,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. OFI Invest Asset Management bought a new stake in shares of CME Group during the 3rd quarter valued at $25,000. MayTech Global Investments LLC acquired a new stake in CME Group during the fourth quarter worth about $25,000. Power Corp of Canada bought a new position in CME Group in the 1st quarter valued at about $26,000. Providence Capital Advisors LLC acquired a new position in shares of CME Group in the 1st quarter valued at approximately $30,000. Finally, Harbor Investment Advisory LLC lifted its holdings in shares of CME Group by 966.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 145 shares during the period. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CME shares. Morgan Stanley lifted their price objective on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. The Goldman Sachs Group cut shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a report on Wednesday, January 3rd. Rosenblatt Securities restated a “sell” rating and issued a $180.00 price target on shares of CME Group in a research note on Thursday, January 4th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Barclays raised their target price on shares of CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research report on Monday, April 8th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $215.70.

Check Out Our Latest Stock Analysis on CME Group

CME Group Price Performance

Shares of NASDAQ CME opened at $213.04 on Monday. The company has a market capitalization of $76.69 billion, a PE ratio of 24.02, a P/E/G ratio of 6.04 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $175.73 and a twelve month high of $223.80. The firm has a fifty day simple moving average of $214.42 and a 200 day simple moving average of $211.83.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the company posted $1.92 EPS. The business’s quarterly revenue was up 19.2% on a year-over-year basis. On average, sell-side analysts forecast that CME Group Inc. will post 9.57 EPS for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.10. This represents a $4.60 annualized dividend and a dividend yield of 2.16%. CME Group’s dividend payout ratio (DPR) is currently 51.86%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.